Erschienen in:
08.09.2022 | Leitthema
Bioactivation of scaffolds in osteonecrosis
verfasst von:
Univ.-Prof. Dr. M. Jäger, A. Busch, A. Sowislok
Erschienen in:
Die Orthopädie
|
Ausgabe 10/2022
Einloggen, um Zugang zu erhalten
Abstract
Avascular osteonecrosis (AVN) due to local ischemia leads to an inhomogeneous osseous defect, which can be treated by resection and with bone substitute materials in a joint-preserving treatment. Due to the underlying risk profile of AVN, the mostly subchondral localization and the size of the local bone defect, bone regeneration is impaired. Therefore, bioactivation of the applied bone substitute materials prior to application is highly desirable. Apart from the use of growth factors and other soluble substances, the autologous application of location-typical cells and tissue is a useful alternative to support the bone healing properties of scaffolds. This article presents various methods to activate scaffolds for bone stimulation and discusses these techniques with respect to recent data from the literature.